Pyrazolo[1,5a]pyrimidine compounds as antiviral agents
US7196111B2 · kind B2 · utility
3Cited by
5References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 2003 |
| Grant date | Mar 27, 2007 |
| Priority date | — |
| Expiry date | Jan 31, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the inhibition of hepatitis C virus (HCV) replication. In particular, embodiments of the invention provide compounds and methods for inhibiting HCV RNA-dependent RNA polymerase enzymatic activity. The invention also provides compositions and methods for the prophylaxis and treatment of HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.